Initial Experience of Platelet Glycoprotein IIb/IIIa Inhibition With Abciximab During Carotid Stenting
Samir Kapadia(Cleveland Clinic), Jay S. Yadav(Piedmont Atlanta Hospital), Kenneth Ouriel(Reproductive Medicine Associates of New York), Mitchell Silver(Cleveland Clinic), Oussama M. Wazni(Cleveland Clinic), Christopher Bajzer(Cleveland Clinic), Khaled M. Ziada(Cleveland Clinic), Edwin G. Beven(Cleveland Clinic), Deepak L. Bhatt(Mount Sinai Hospital)
Cited by 75
Related Papers
Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients
|New England Journal of Medicine|2011|6.4k
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients
|New England Journal of Medicine|2016|5.1k
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients
|New England Journal of Medicine|2019|4.8k
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
|New England Journal of Medicine|2018|3.5k